Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone MarrowBone Marrow TransplantationTransplantation, HomologousLeukapheresisGranulocyte Colony-Stimulating FactorBone Marrow CellsHematopoietic Stem CellsGraft vs Host DiseaseStem CellsGraft SurvivalBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsMelphalanCyclophosphamideCombined Modality TherapyBone and BonesMultiple MyelomaStem Cell TransplantationBlood CellsBusulfanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountHematopoiesisTreatment OutcomeImmunosuppressive AgentsCord Blood Stem Cell TransplantationBone Marrow PurgingLymphoma, Non-HodgkinKidney TransplantationGraft RejectionTissue DonorsEtoposideTime FactorsAntineoplastic Agents, AlkylatingMyeloablative AgonistsTransplantation ChimeraRecurrenceThiotepaWhole-Body IrradiationCyclosporineHistocompatibilityRemission InductionChronic DiseaseLeukemiaColony-Forming Units AssayFlow CytometryCell DifferentiationHistocompatibility TestingPlatelet CountCell SeparationIfosfamideBlood DonorsAnemia, AplasticCells, CulturedImmunophenotypingEmbryonic Stem CellsCytarabineTransplantation, IsogeneicDisease-Free SurvivalLeukocytes, MononuclearInfectionLeukocyte CountRetrospective StudiesAdult Stem CellsRecombinant ProteinsLeukemia, Myeloid, AcuteBone RemodelingVidarabinePOEMS SyndromeSurvival RateVincristineSalvage TherapyImmunomagnetic SeparationBone Marrow ExaminationAntigens, CDHodgkin DiseaseStem Cell FactorLymphomaSurvival AnalysisT-LymphocytesBone Marrow NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsCarmustineMyelodysplastic SyndromesLymphocyte DepletionRats, Inbred LewGranulocytesHematologic DiseasesPlatelet TransfusionProchlorperazinePluripotent Stem CellsGranulocyte-Macrophage Colony-Stimulating Factor